Comparison of CT methods for determining the fat content of the liver

Yoshihisa Kodama, Chaan S. Ng, Tsung T. Wu, Gregory D. Ayers, Steven A. Curley, Eddie K. Abdalla, Jean Nicolas Vauthey, Chusilp Charnsangavej

Research output: Contribution to journalArticle

222 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this study was to assess which of a number of methods of measuring attenuation on CT scans is best for prediction of hepatic fat content. MATERIALS AND METHODS. This retrospective study was approved by our institutional review board. Consecutively registered patients who underwent liver resection for metastatic disease formed the study group. Attenuation measurements were obtained from 12 regions of interest in the liver and three in the spleen on both unenhanced and portal phase contrast-enhanced preoperative hepatic CT images. Hepatic attenuation measurements were analyzed both with and without normalization with the spleen. Normalization included both differences and ratios between hepatic and splenic attenuation values. Pathologic fat content was graded semiquantitatively as a percentage of the nonneoplastic liver parenchyma of the resected specimen. Average attenuation values of the liver were compared with pathologic fat content, as were the differences and ratios between hepatic and splenic attenuation values. Linear regression analysis was conducted on a log-log scale. RESULTS. Data on 88 patients were analyzed. On unenhanced and contrast-enhanced CT images, all associations between pathologic fat content and attenuation measurements were significant (p < 0.0001). All series of R2 values for unenhanced CT scans were much higher than those for contrast-enhanced CT scans. The R2 values of liver-only measurement were higher than those of hepatic values normalized with splenic values on both unenhanced (0.646-0.649 > 0.523, 0.565) and contrast-enhanced (0.516 > 0.242, 0.344) CT. CONCLUSION. Measurement of attenuation of liver only on unenhanced CT scans is best for prediction of pathologic fat content.

Original languageEnglish (US)
Pages (from-to)1307-1312
Number of pages6
JournalAmerican Journal of Roentgenology
Volume188
Issue number5
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

Fats
Liver
Spleen
Research Ethics Committees
Linear Models
Retrospective Studies
Regression Analysis

Keywords

  • CT
  • Fat measurement
  • Liver disease

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Kodama, Y., Ng, C. S., Wu, T. T., Ayers, G. D., Curley, S. A., Abdalla, E. K., ... Charnsangavej, C. (2007). Comparison of CT methods for determining the fat content of the liver. American Journal of Roentgenology, 188(5), 1307-1312. https://doi.org/10.2214/AJR.06.0992

Comparison of CT methods for determining the fat content of the liver. / Kodama, Yoshihisa; Ng, Chaan S.; Wu, Tsung T.; Ayers, Gregory D.; Curley, Steven A.; Abdalla, Eddie K.; Vauthey, Jean Nicolas; Charnsangavej, Chusilp.

In: American Journal of Roentgenology, Vol. 188, No. 5, 05.2007, p. 1307-1312.

Research output: Contribution to journalArticle

Kodama, Y, Ng, CS, Wu, TT, Ayers, GD, Curley, SA, Abdalla, EK, Vauthey, JN & Charnsangavej, C 2007, 'Comparison of CT methods for determining the fat content of the liver', American Journal of Roentgenology, vol. 188, no. 5, pp. 1307-1312. https://doi.org/10.2214/AJR.06.0992
Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK et al. Comparison of CT methods for determining the fat content of the liver. American Journal of Roentgenology. 2007 May;188(5):1307-1312. https://doi.org/10.2214/AJR.06.0992
Kodama, Yoshihisa ; Ng, Chaan S. ; Wu, Tsung T. ; Ayers, Gregory D. ; Curley, Steven A. ; Abdalla, Eddie K. ; Vauthey, Jean Nicolas ; Charnsangavej, Chusilp. / Comparison of CT methods for determining the fat content of the liver. In: American Journal of Roentgenology. 2007 ; Vol. 188, No. 5. pp. 1307-1312.
@article{145ffcc892f045699be9048242db040a,
title = "Comparison of CT methods for determining the fat content of the liver",
abstract = "OBJECTIVE. The purpose of this study was to assess which of a number of methods of measuring attenuation on CT scans is best for prediction of hepatic fat content. MATERIALS AND METHODS. This retrospective study was approved by our institutional review board. Consecutively registered patients who underwent liver resection for metastatic disease formed the study group. Attenuation measurements were obtained from 12 regions of interest in the liver and three in the spleen on both unenhanced and portal phase contrast-enhanced preoperative hepatic CT images. Hepatic attenuation measurements were analyzed both with and without normalization with the spleen. Normalization included both differences and ratios between hepatic and splenic attenuation values. Pathologic fat content was graded semiquantitatively as a percentage of the nonneoplastic liver parenchyma of the resected specimen. Average attenuation values of the liver were compared with pathologic fat content, as were the differences and ratios between hepatic and splenic attenuation values. Linear regression analysis was conducted on a log-log scale. RESULTS. Data on 88 patients were analyzed. On unenhanced and contrast-enhanced CT images, all associations between pathologic fat content and attenuation measurements were significant (p < 0.0001). All series of R2 values for unenhanced CT scans were much higher than those for contrast-enhanced CT scans. The R2 values of liver-only measurement were higher than those of hepatic values normalized with splenic values on both unenhanced (0.646-0.649 > 0.523, 0.565) and contrast-enhanced (0.516 > 0.242, 0.344) CT. CONCLUSION. Measurement of attenuation of liver only on unenhanced CT scans is best for prediction of pathologic fat content.",
keywords = "CT, Fat measurement, Liver disease",
author = "Yoshihisa Kodama and Ng, {Chaan S.} and Wu, {Tsung T.} and Ayers, {Gregory D.} and Curley, {Steven A.} and Abdalla, {Eddie K.} and Vauthey, {Jean Nicolas} and Chusilp Charnsangavej",
year = "2007",
month = "5",
doi = "10.2214/AJR.06.0992",
language = "English (US)",
volume = "188",
pages = "1307--1312",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "5",

}

TY - JOUR

T1 - Comparison of CT methods for determining the fat content of the liver

AU - Kodama, Yoshihisa

AU - Ng, Chaan S.

AU - Wu, Tsung T.

AU - Ayers, Gregory D.

AU - Curley, Steven A.

AU - Abdalla, Eddie K.

AU - Vauthey, Jean Nicolas

AU - Charnsangavej, Chusilp

PY - 2007/5

Y1 - 2007/5

N2 - OBJECTIVE. The purpose of this study was to assess which of a number of methods of measuring attenuation on CT scans is best for prediction of hepatic fat content. MATERIALS AND METHODS. This retrospective study was approved by our institutional review board. Consecutively registered patients who underwent liver resection for metastatic disease formed the study group. Attenuation measurements were obtained from 12 regions of interest in the liver and three in the spleen on both unenhanced and portal phase contrast-enhanced preoperative hepatic CT images. Hepatic attenuation measurements were analyzed both with and without normalization with the spleen. Normalization included both differences and ratios between hepatic and splenic attenuation values. Pathologic fat content was graded semiquantitatively as a percentage of the nonneoplastic liver parenchyma of the resected specimen. Average attenuation values of the liver were compared with pathologic fat content, as were the differences and ratios between hepatic and splenic attenuation values. Linear regression analysis was conducted on a log-log scale. RESULTS. Data on 88 patients were analyzed. On unenhanced and contrast-enhanced CT images, all associations between pathologic fat content and attenuation measurements were significant (p < 0.0001). All series of R2 values for unenhanced CT scans were much higher than those for contrast-enhanced CT scans. The R2 values of liver-only measurement were higher than those of hepatic values normalized with splenic values on both unenhanced (0.646-0.649 > 0.523, 0.565) and contrast-enhanced (0.516 > 0.242, 0.344) CT. CONCLUSION. Measurement of attenuation of liver only on unenhanced CT scans is best for prediction of pathologic fat content.

AB - OBJECTIVE. The purpose of this study was to assess which of a number of methods of measuring attenuation on CT scans is best for prediction of hepatic fat content. MATERIALS AND METHODS. This retrospective study was approved by our institutional review board. Consecutively registered patients who underwent liver resection for metastatic disease formed the study group. Attenuation measurements were obtained from 12 regions of interest in the liver and three in the spleen on both unenhanced and portal phase contrast-enhanced preoperative hepatic CT images. Hepatic attenuation measurements were analyzed both with and without normalization with the spleen. Normalization included both differences and ratios between hepatic and splenic attenuation values. Pathologic fat content was graded semiquantitatively as a percentage of the nonneoplastic liver parenchyma of the resected specimen. Average attenuation values of the liver were compared with pathologic fat content, as were the differences and ratios between hepatic and splenic attenuation values. Linear regression analysis was conducted on a log-log scale. RESULTS. Data on 88 patients were analyzed. On unenhanced and contrast-enhanced CT images, all associations between pathologic fat content and attenuation measurements were significant (p < 0.0001). All series of R2 values for unenhanced CT scans were much higher than those for contrast-enhanced CT scans. The R2 values of liver-only measurement were higher than those of hepatic values normalized with splenic values on both unenhanced (0.646-0.649 > 0.523, 0.565) and contrast-enhanced (0.516 > 0.242, 0.344) CT. CONCLUSION. Measurement of attenuation of liver only on unenhanced CT scans is best for prediction of pathologic fat content.

KW - CT

KW - Fat measurement

KW - Liver disease

UR - http://www.scopus.com/inward/record.url?scp=34247635484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247635484&partnerID=8YFLogxK

U2 - 10.2214/AJR.06.0992

DO - 10.2214/AJR.06.0992

M3 - Article

VL - 188

SP - 1307

EP - 1312

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 5

ER -